fbpx
  • Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • Gadgets & Electronics
    • Health & Bio
    • FinTech
    • IoT
    • Transportation & Logistics
    • Marketplaces & E-commerce
    • Ecosystem
    • Robotics
    • Investments
    • EdTech
    • Featured
  • Deals
    • Private Equity
    • Venture Capital
    • IPO & Markets
  • Interviews
    • Investors’ interviews
    • Founders’ interviews
  • Governments
  • Lists
  • MORE
    • Events
    • Startups Advice
  • Submit an Article
  • REGISTER
  • login
No Result
View All Result
No Result
View All Result
Home Health & Bio

BioMe Inc. & Yonsei Medical Center sign technology transfer contract for pathbreaking microbiome treatment

AsiaTechDaily Writer by AsiaTechDaily Writer
30 December 2021
in Health & Bio
0
BioMe is working on microbe therapeutics.

BioMe is working on microbe therapeutics.

0
SHARES
Share on FacebookShare on Twitter
Bookmark (0)

Please login to bookmark

No account yet? Register

The microbiome treatment market is receiving global attention and is rapidly emerging as a new treatment alternative for various intractable diseases. However, recent clinical trial failure reports and the limitation to identify a clear mode of action demand a careful approach. Korea-based company BioMe Inc. wants to bring in disruption with pathbreaking microbiome-based therapeutics. 

Established in November 2020 by Professor Sang Sun Yoon of the Department of Microbiology and Immunology, Yonsei University College of Medicine, BioMe Inc. has been developing a microbiome-based live biotherapeutic product (LBP). Based on the distinguished microbiology research foundation of Yonsei University College of Medicine, BioMe Inc. 

(i) understands the bacteriological characteristics of the candidate strains, 

(ii) can prove its effectiveness using animal disease models, made possible in the state-of-the-art Avison Biomedical Research Centre.

To accelerate its research & development process, the startup recently signed a technology transfer contract with Yonsei University College of Medicine. BioMe Inc. would start developing microbiome-based therapeutics with the six patents transferred from Yonsei University College of Medicine.

The technology transfer under the contract includes a total of six patents, and BioMe’s development pipeline is as follows: 

No. Development Pipeline
1 A protein derived from airway microbiome with inhibitory effects against broad-spectrum respiratory infections
2 A microbiome-derived immune enhancing protein with clear anti-cancer effect
3 A skin microbiome showing efficacy in treating atopic dermatitis
4 A consortium of commensal microbes showing efficacy in treating inflammatory bowel disease
5 Novel synbiotics system inducing butyrate synthesis

In addition to the above technology, a novel pipeline capable of degrading TMA, a risk factor for cardiovascular disease, is under development by BioMe Inc.

Beyond discovering useful strains, BioMe Inc. is building a microbiome-based system that selectively produces beneficial metabolites or degrades hazardous counterparts. This development strategy represented by “Molecule First” is implemented through the iBTSTM (integrated BioMe Technology for Screen) platform.

Recently, Kim Bu Seon, a former managing director of SK Bioscience, has been recruited to design target product profiles for candidate strains. Preclinical trials are scheduled to begin in the first half of 2022, and clinical trials will begin in 2023.

Previous Post

Indonesia’s Bukalapak names Willix Halim as interim CEO

Next Post

Singapore startup CyberHash raises $20m in Lemon-led funding

Related Posts

edit post
Awak Technologies Raises Over $20M in Series B Funding for Home Dialysis Innovation
Health & Bio

Awak Technologies Raises Over $20M in Series B Funding for Home Dialysis Innovation

September 19, 2023
edit post
Thailand’s HD Receives Funding Boost from FEBE Ventures to Expand Healthcare Solutions in Vietnam
Health & Bio

Thailand’s HD Receives Funding Boost from FEBE Ventures to Expand Healthcare Solutions in Vietnam

August 1, 2023
edit post
Health2Sync Founder & CEO, Ed Deng. Credit: Cherubic Ventures
Featured

Health2Sync Founder Ed Deng wants to solve the problems around chronic disease management

July 17, 2023
edit post
VentureBlick Raises $2.6M for Two Health Startups, Introduces Medtech Super Incubator
Health & Bio

VentureBlick Raises $2.6M for Two Health Startups, Introduces Medtech Super Incubator

July 5, 2023
edit post
Adicon plans to raise $52.29 Million in Hong Kong Listing through Global Offering
Health & Bio

Adicon plans to raise $52.29 Million in Hong Kong Listing through Global Offering

June 19, 2023
edit post
Singapore-based Telehealth Platform ORA Raises $10 Million in Series A Funding Round
Founders' interviews

Singapore-based Telehealth Platform ORA Raises $10 Million in Series A Funding Round

May 18, 2023
Next Post
edit post
CyberHash

Singapore startup CyberHash raises $20m in Lemon-led funding

Discussion about this post

No Result
View All Result

Popular Posts

  • The Top 5 Dating Apps In Asia – 2023

    69 shares
    Share 28 Tweet 17
  • Japanese EV Startup Terra Motors Raises $28 M in Series C Funding for Infrastructure Expansion

    36 shares
    Share 14 Tweet 9
  • How Rohan Gupta Co-Founder And CEO Of QuillBot Raised $4.25M To Make Writing Painless?

    16 shares
    Share 6 Tweet 4
  • How Roland Ros, Founder Of Kumu Raised $6M To Build The #1 Grossing Social App In the Philippines?

    14 shares
    Share 6 Tweet 4
  • Inshorts CEO Azhar Iqubal: The entrepreneur who got news curated for the Millenials & Gen Z 

    14 shares
    Share 6 Tweet 4
  • Kimberly Yao, CEO And Co-Founder Of CloudEats- A Pioneer Cloud Restaurant Company In SouthEast Asia

    13 shares
    Share 5 Tweet 3
  • Indian FinTech startup Jar raises US$32 million in Series A

    10 shares
    Share 4 Tweet 3
  • Yoma Strategic announces plan to acquire Telenor Group’s stake in Wave Money

    9 shares
    Share 4 Tweet 2
  • Top 5 Cross-Border Acquisitions To Eye for in 2023

    9 shares
    Share 4 Tweet 2
  • Atome Financial and HSBC Singapore Collaborate Again to Expand in the Philippine Market

    9 shares
    Share 4 Tweet 2




  •  Australia
  •  Austria
  •  Bangladesh
  •  Bhutan
  •  Brunei
  •  Bulgaria
  •  Cambodia
  •  Canada
  •  China
  •  Dubai
  •  Europe
  •  Finland
  •  France
  •  Germany
  •  Greater China
  •  Hong Kong
  •  India
  •  Indonesia
  •  Ireland
  •  Israel
  •  Japan
  •  Laos
  •  Lithuania
  •  Malaysia
  •  Mexico
  •  Mongolia
  •  Myanmar
  •  Nepal
  •  Netherlands
  •  New Zealand
  •  Norway
  •  Pakistan
  •  Philippines
  •  Poland
  •  Puerto Rico
  •  Qatar
  •  Russia
  •  Signapore
  •  Singapore
  •  South Korea
  •  Sweden
  •  Switzerland
  •  Taiwan
  •  Thailand
  •  Turkey
  •  Ukraine
  •  United
  •  United Kingdom
  •  United States
  •  Uzbekistan
  •  Vietnam

Topics

  • AI & Big Data
  • AR & VR
  • Blockchain
  • Clean Technology
  • Content & Games
  • Cybersecurity
  • Enterprise & SaaS
  • Gadgets & Electronics
  • Health & Bio

  • Ecosystem
  • EdTech
  • Featured
  • FinTech
  • Investments
  • IoT
  • Marketplaces & E-commerce
  • Robotics
  • Transportation & Logistics

FREE NEWSLETTER

Follow Us

Copyright © 2023 AsiaTechDaily.com| About Us | Seed accelerator| Terms of Use| Privacy Policy| Cookie Policy Contact : [email protected] | DMCA.com Protection Status | trusted by Wimgo

No Result
View All Result
  • Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • Gadgets & Electronics
    • Health & Bio
    • FinTech
    • IoT
    • Transportation & Logistics
    • Ecosystem
    • Marketplaces & E-commerce
    • Robotics
    • Investments
    • Featured
  • Deals
    • Private Equity
    • Venture Capital
    • IPO & Markets
  • Interviews
    • Investors’ interviews
    • Founders’ interviews
  • Governments
  • Lists
  • MORE
    • Events
    • Startups Advice
  • Submit an Article
  • Forums
  • Jobs
  • REGISTER
  • Login

Copyright © 2023 AsiaTechDaily.com| About Us | Seed accelerator| Terms of Use| Privacy Policy| Cookie Policy Contact : [email protected] | DMCA.com Protection Status | trusted by Wimgo

We hope you enjoy our content, May you please give us Feedback regarding our website!

Single Post Feedback